Last month the Federal Circuit affirmed a PTAB inter partes review (IPR) decision finding that the University of Minnesota’s patent claim directed to the anti-cancer drug sofosbuvir was not adequately supported by the written...more
4/20/2023
/ Claim Construction ,
Disclosure ,
Inter Partes Review (IPR) Proceeding ,
Inventors ,
Patent Applications ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Section 112 ,
Written Descriptions
The Federal Circuit’s recent decision in Minerva Surgical, Inc. v. Hologic, Inc. provides a timeline reminder to inventors and patent applicants: Do not bring your invention into public view before you have filed your patent...more
Patent and trademark offices around the world have not been insulated from the effects of the global coronavirus pandemic. Many offices have directed their employees to transition to telework, and several have extended...more
3/23/2020
/ Canadian Intellectual Property Office (CIPO) ,
Coronavirus/COVID-19 ,
Filing Deadlines ,
Filing Requirements ,
France ,
Germany ,
India ,
Intellectual Property Protection ,
Office Closures ,
Patent Applications ,
Patents ,
Relief Measures ,
State of Emergency ,
Trademark Application ,
Trademarks ,
UK Intellectual Property Office (UK IPO) ,
USPTO
In Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., the Supreme Court held on Tuesday that “private” or “confidential sales” are still prior art despite the amendments to U.S. patent law enacted by the America...more
1/24/2019
/ America Invents Act ,
Appeals ,
Assignment of Inventions ,
Confidentiality Agreements ,
Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc ,
Inventions ,
On-Sale Bar ,
Patent Applications ,
Patent Infringement ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Public Use ,
Reaffirmation ,
Reversal ,
SCOTUS ,
Section 102 ,
Third-Party Relationships
The recent Actelion Pharmaceuticals Ltd. case brought to light a little-known quirk in how national stage patent applications affect the length of one’s patent term. That case involved a drug company losing five days of...more
5/17/2018
/ America Invents Act ,
Claim Construction ,
Fees ,
Filing Deadlines ,
Intellectual Property Protection ,
Patent Applications ,
Patent Cooperation Treaty ,
Patent Examinations ,
Patent Filings ,
Patent Reform ,
Patent Terms ,
Patents ,
PLTIA ,
Strategic Planning ,
USPTO
Recent court decisions have confirmed that inventors run the risk of destroying their patent rights in the U.S. and abroad if they publicize their inventions or put them “on sale” before applying for a patent....more